107 related articles for article (PubMed ID: 8239903)
1. Synthesis and biological properties of 5-hydroxy-methylpyrimidines.
Cieplik J; Machoń Z; Zimecki M; Wieczorek Z
Arch Immunol Ther Exp (Warsz); 1993; 41(1):11-5. PubMed ID: 8239903
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and antineoplastic effects of furo[3,4-d]pyrimidine derivatives.
Machoń Z; Cieplik J
Pol J Pharmacol Pharm; 1988; 40(2):201-8. PubMed ID: 3237569
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and antitumor properties of pyrazolo [3,4-D] pyrimidine derivatives.
Witkiewicz K; Machoń Z; Mordarski M; Wieczorek J
Pol J Pharmacol Pharm; 1987; 39(6):715-20. PubMed ID: 3503990
[TBL] [Abstract][Full Text] [Related]
4. Isothiazolopyrimidines--new group of anticancer agents. I.
Machoń Z; Wieczorek J; Mordarski M
Arch Immunol Ther Exp (Warsz); 1987; 35(5):599-607. PubMed ID: 3455649
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and pharmacological properties of derivatives of isoxazolo [5,4-d]-6,7-dihydropyrimidines.
Machoń Z; Ryng S
Pol J Pharmacol Pharm; 1988; 40(2):209-16. PubMed ID: 3237570
[TBL] [Abstract][Full Text] [Related]
6. Derivatives of 2-hydroxy-4-mercapto-6-methylpyrimidine-5-carboxylic acid. II. Pirazolo-[3,4-d]-pyrimidine and hydrazinopyrimidine.
Machoń Z; Dlugosz A
Pol J Pharmacol Pharm; 1976; 28(5):511-20. PubMed ID: 1012978
[TBL] [Abstract][Full Text] [Related]
7. Pneumocystis carinii and Toxoplasma gondii dihydrofolate reductase inhibitors and antitumor agents: synthesis and biological activities of 2,4-diamino-5-methyl-6-[(monosubstituted anilino)methyl] pyrido[2,3-d]pyrimidines.
Gangjee A; Adair O; Queener SF
J Med Chem; 1999 Jul; 42(13):2447-55. PubMed ID: 10395486
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and properties of 7-methyl-5-oxo-1,5-dihydro-8-[1,2,4]-triazolo [4,3-c]pyrimidinecarboxylic acid derivatives.
Długosz A; Machoń Z; Jasztold-Howorko R
Pharmazie; 1989 Sep; 44(9):604-5. PubMed ID: 2608705
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and biological evaluation of 2,4-diamino-6-(arylaminomethyl)pyrido[2,3-d]pyrimidines as inhibitors of Pneumocystis carinii and Toxoplasma gondii dihydrofolate reductase and as antiopportunistic infection and antitumor agents.
Gangjee A; Adair OO; Queener SF
J Med Chem; 2003 Nov; 46(23):5074-82. PubMed ID: 14584957
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and pharmacological properties of 1-[2-hydroxy-3-(4-o,m,p-halogenophenyl)- and 3-(4-m-chlorophenyl)-1-piperazinyl]propyl derivatives of amides of 7-methyl-3-phenyl-2,4-dioxo-1,2,3,4-tetrahydropyrido [2,3-d]pyrimidine-5-carboxylic acid with analgesic and sedative activities.
Sabiniarz A; Sladowska H; Filipek B; Sapa J; Dudek M; Slepokura K
Acta Pol Pharm; 2007; 64(4):369-76. PubMed ID: 18536164
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and antiviral and cytostatic evaluations of the new C-5 substituted pyrimidine and furo[2,3-d]pyrimidine 4',5'-didehydro-L-ascorbic acid derivatives.
Gazivoda T; Sokcević M; Kralj M; Suman L; Pavelić K; De Clercq E; Andrei G; Snoeck R; Balzarini J; Mintas M; Raić-Malić S
J Med Chem; 2007 Aug; 50(17):4105-12. PubMed ID: 17672445
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and cytotoxicity of the three-membered aromatic pyrimidine derivatives.
Długosz A
Acta Pol Pharm; 1997; 54(5):357-62. PubMed ID: 9584693
[TBL] [Abstract][Full Text] [Related]
13. Pyrimidines as the cytostatic drugs.
Cieplik J
Acta Pol Pharm; 1992; 49(4):51-7. PubMed ID: 16092436
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and cytostatic properties of 5-substituted derivatives of 3-methylisoxazolo[5,4-d]1,2,3-triazine-4-ones and 3-methyl-5-triazene 4-isoxazolecarboxylic acid ethyl esters.
Ryng S; Malinka W; Duś D
Farmaco; 1997 Feb; 52(2):105-8. PubMed ID: 9181691
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and biological evaluation of certain new thiazolopyrimidines.
el-Bendary ER; el-Sherbeny MA; Badria FA
Boll Chim Farm; 1998 Apr; 137(4):115-9. PubMed ID: 9618969
[TBL] [Abstract][Full Text] [Related]
16. Pyrimidines. Part II: Synthesis of novel pyrimidines, 1,2,4-triazolo[4,3-a]pyrimidin-7-ones and pyrimidino[2,1-c][1,2,4]triazin-8-ones for their antimicrobial and anticancer activities.
Habib NS; Soliman R; Ismail K; Hassan AM; Sarg MT
Boll Chim Farm; 2003 Nov; 142(9):396-405. PubMed ID: 14971308
[TBL] [Abstract][Full Text] [Related]
17. [Synthesis of sulfanylalkylpyrimidine derivatives with potential immunomodulating action].
Briel D; Holzer M; Leistner S; Drössler K; Dobner B
Pharmazie; 2003 Oct; 58(10):759-60. PubMed ID: 14609293
[No Abstract] [Full Text] [Related]
18. Synthesis and bactericidal properties of ethyl 4-sulfonamido pyrimidine 5-carboxylate derivatives.
Cieplik J; Pluta J; Gubrynowicz O
Boll Chim Farm; 2003 Jun; 142(5):206-10. PubMed ID: 14526652
[TBL] [Abstract][Full Text] [Related]
19. Synthesis of flavone-2'-carboxylic acid analogues as potential antitumor agents.
Valenti P; Bisi A; Rampa A; Gobbi S; Belluti F; Da Re P; Cima L; Carrara M
Anticancer Drug Des; 1998 Dec; 13(8):881-92. PubMed ID: 10335265
[TBL] [Abstract][Full Text] [Related]
20. [Synthesis and antibacterial and antitumoral activity of some methylhydrazonium salts of pyrimidine bases and their analogues (author's transl)].
Golovinsky E; Karamanov G; Spassovska N; Maneva L; Spassov A
Pharmazie; 1982 May; 37(5):355-6. PubMed ID: 7111362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
